Our data revealed that Iba1+ microglia and GFAP+ astrocytes were significantly active across the hippocampus’s focal area in the TI-induced stroke group, in comparison with those of the OLNZ treatment and sham groups. The gene discussed is GFAP; the disease is stroke disorder.